Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?: Con: Do no harm to asymptomatic carriers

Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant? Con: Do no harm to asymptomatic carriers

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3 Downloads (Pure)

@article{558e008769194565842f7e21a9e63c69,

title = "Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?: Con: Do no harm to asymptomatic carriers",

author = "Doevendans, \{Pieter A.\}",

year = "2023",

month = aug,

doi = "10.1007/s12471-023-01794-z",

language = "English",

volume = "31",

pages = "289--290",

journal = "Netherlands Heart Journal",

issn = "1568-5888",

publisher = "Bohn Stafleu van Loghum",

number = "7-8",

}

TY - JOUR

T1 - Should we offer preventive treatment to all carriers of PLN p.(Arg14del) variant?

T2 - Con: Do no harm to asymptomatic carriers

AU - Doevendans, Pieter A.

PY - 2023/8

Y1 - 2023/8

UR - https://www.scopus.com/pages/publications/85165484123

U2 - 10.1007/s12471-023-01794-z

DO - 10.1007/s12471-023-01794-z

M3 - Comment/Letter to the editor

AN - SCOPUS:85165484123

SN - 1568-5888

VL - 31

SP - 289

EP - 290

JO - Netherlands Heart Journal

JF - Netherlands Heart Journal

IS - 7-8

ER -